|1.||Volpini, Rosaria: 2 articles (06/2009 - 04/2005)|
|2.||Cristalli, Gloria: 2 articles (06/2009 - 04/2005)|
|3.||Dal Ben, Diego: 1 article (06/2009)|
|4.||Ramadori, Anna Teresa: 1 article (06/2009)|
|5.||Mishra, Ram Chandra: 1 article (06/2009)|
|6.||Lambertucci, Catia: 1 article (06/2009)|
|7.||Klotz, Karl-Norbert: 1 article (06/2009)|
|8.||Trincavelli, Maria Letizia: 1 article (06/2009)|
|9.||Marucci, Gabriella: 1 article (06/2009)|
|10.||Martini, Claudia: 1 article (06/2009)|
|1.||Parkinson Disease (Parkinson's Disease)
04/11/2005 - "Taken together the results of this study indicate that some 8-substituted 9-ethyladenine derivatives ameliorate motor deficits in rat models of Parkinson's disease, suggesting a potential therapeutic role of these compounds."
06/01/2009 - "Recently, three 9-ethyladenine derivatives bearing a bromine atom, an ethoxy group, and a furyl ring, respectively, in the 8-position have been reported to ameliorate motor deficits in rat Parkinson's disease models, suggesting a potential therapeutic role for these compounds. "
|2.||Colorectal Neoplasms (Colorectal Cancer)
|3.||Lesch-Nyhan Syndrome (Choreoathetosis Self Mutilation Hyperuricemia Syndrome)
10/01/1998 - "It has been reported that 9-ethyladenine (9-EA) is an efficient inhibitor of APRT (adenine phosphoribosyltransferase) and that its administration causes self-injurious behavior (Lesch-Nyhan Syndrome-like symptoms) in HPRT (hypoxanthine-guanine phosphoribosyltransferase)-deficient mice. "
|1.||Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)